Jianxin Guo
Director, Regulatory CMC Biotechnology Eli Lilly & Co.
Seminars
Monday 12th October 2026
Elevating Confident Characterization of Increasingly Complex Conjugates
Monday 12th October 2026
Laying Out ADC CQAs & Understanding Regulatory Quality Perspectives as Complex Biologic & Small Molecule Therapies
9:30 am
- Contextualizing CQA requirements from approved and marketed ADCs
- Breaking down CQA considerations across small molecule and biologic ADC components
- Supplementing CQA expectations with regulatory CMC guidance from available Health Authority published guidelines
